NOTCH3 and cerebral microbleeds: In contrast, the lacunes and cerebral microbleeds in patients with NOTCH3 cysteine-sparing mutations were more severe than those in typical CADASIL (74.29% vs. 62.00%, 72.73% vs. 35.80%, respectively), particularly for cerebral microbleeds with a significantly statistically higher proportion.